Acute Influence of Cigarette Smoke on Secretion of Pulmonary Surfactant in Rat Alveolar Type II Cells in Culture
Total Page:16
File Type:pdf, Size:1020Kb
Eur Respir J, 1996, 9, 24–32 Copyright ERS Journals Ltd 1996 DOI: 10.1183/09031936.96.09010024 European Respiratory Journal Printed in UK - all rights reserved ISSN 0903 - 1936 Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture H.R.W. Wirtz, M. Schmidt Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar Dept of Medicine, University of Würzburg, type II cells in culture. H.R.W. Wirtz, M. Schmidt. ©ERS Journals Ltd 1996. Würzburg, Germany. ABSTRACT: It has been shown, that smoking results in a lower yield of surfac- tant associated phospholipids in bronchoalveolar lavage (BAL). Indirect evidence Correspondence: H.R.W. Wirtz suggests impaired secretion. In the present study, we investigated the influence of Medizinische Klinik cigarette smoke on surfactant secretion in cultured rat alveolar type II cells. Universität Würzburg Smoke exposure was achieved by bubbling the smoke of four cigarettes through Josef Schneider Str. 2 Dulbecco's modified Eagle's medium (DMEM) which was adjusted to a reference 97080 Würzburg absorption value of 1.36 at 320 nm. Cells were preincubated with various dilutions Germany of cigarette smoke-treated medium for 30 min, and were then exposed to this medi- um for 2 h. After this time, secretion of 3H-choline-labelled phosphatidylcholine Keywords: Antioxidants (PC) was measured as a marker of surfactant secretion. cigarette smoke A 10 fold dilution of cigarette smoke-treated medium inhibited PC secretion stimu- surfactant secretion lated by a combination of terbutaline, adenosine triphosphate and 12-O-tetrade- type II cells canoylphorbol-13-acetate by over 50%, but did not alter basal secretion. Exposure to less concentrated cigarette smoke-treated medium resulted in less inhibition. Received: September 12 1994 Cellular injury was not observed with the concentrations of cigarette smoke-treat- Accepted after revision October 7 1995 ed medium used in this study. The gas phase of cigarette smoke was not inhibi- tory at comparable concentrations. Longer exposure to cigarette smoke-treated medium resulted in increased inhibition of PC secretion. The cigarette smoke ingre- This work was supported in part by a grant from Forschungsgesellschaft Rauchen und dients, nicotine and benzo[a]pyrene, failed to inhibit PC secretion. Secretion of type Gesundheit MBH, Germany. II cells exposed to cigarette smoke-treated medium at lower temperatures was not affected. Addition of antioxidants to medium and cells during the preincubation and secretion period did not alter cigarette smoke-treated medium-induced inhibi- tion of stimulated PC secretion. These results demonstrate a direct inhibitory effect of cigarette smoke constituents on surfactant secretion in type II cells. Inhibition is mediated by compounds con- tained predominantly in the particulate phase of cigarette smoke. Inactivation of the inhibitory effect by lower temperatures suggests involvement of processes such as enzymatic bioactivation or active transport mechanisms. Eur Respir J., 1996, 9, 24–32. Evidence that the yield of surfactant-associated phos- cells tends to be larger in smokers than in nonsmokers pholipids in bronchoalveolar lavage fluid of young smok- [6]. Finally, the amount of total surfactant-associated ers is reduced compared to healthy controls dates back phospholipids in the lungs of smokers is not diminished, more than 20 yrs [1], and has recently been confirmed in contrast to the amount of extracellular surfactant, which [2, 3]. However, the influence of cigarette smoking on suggests a disturbance somewhere during the process of the surfactant system has not been well established. secretion [4]. Cessation of smoking resulted in a return of the amount The aim of this study was to investigate the acute of phospholipids to normal levels within 2 weeks [1]. It effects of cigarette smoke on secretion of surfactant. An has been suggested, that structural changes in the lungs in vitro cell culture model was chosen, in order to elim- of smokers might be responsible for the observed reduc- inate the influence of known effects of cigarette smoke tion in phospholipid yield [4], but it seems unlikely that on, for instance, inflammatory cells, and because it facil- these changes would reverse within a short period. Animal itated investigation of the mechanisms. Cell culture medi- experiments resulted in similar findings. Synthesis does um was treated with cigarette smoke and cells were not appear to be affected, as the incorporation rate of exposed to this medium before or during secretion stim- labelled palmitic acid into surfactant phospholipids in ulated by means of agonists. In this study, inhibition of dogs was not altered following exposure to cigarette stimulated secretion of phosphatidylcholine, a marker smoke [5]. In addition, the number of alveolar type II of pulmonary surfactant, was observed in cultured rat CIGARETTE SMOKE AND PC SECRETION IN TYPE II CELLS 25 alveolar type II cells. The extent of inhibition depend- resulting standardization factor was then multiplied by ed on the dose of smoke constituents in the medium and 10, 25, 50, 75 or 100 to give the final factor of dilution. on the time that cells were exposed to it. The role of oxidants and the influence of a reduced metabolic rate induced by low temperature were also investigated. Preparation of gas phase cigarette smoke-treated medi- um Materials and methods For experiments examining the influence of the parti- cle-free phase of cigarette smoke on surfactant secretion, Dulbecco's modified Eagle's medium (DMEM) was a Cambridge Filter (Tobacco & Health Research Institute, purchased from Gibco (Eggenstein, Germany). L-glut- University of Kentucky, USA) was used to filter ciga- amine, penicillin, gentamicin, rat immunoglobulin G rette smoke, which removes 99.9% of the particulate (IgG), deoxyribonuclease (DNase) I, trypsin, ethylene phase [7]. For each cigarette, a new filter was used. The glycol tetra-acetic acid (EGTA), adenosine triphosphate resulting medium was termed gas phase cigarette smoke- (ATP), terbutaline, 12-O-tetradecanoylphorbol-13-acetate treated medium (gpCSTM). Because gpCSTM did not (TPA), (-)-nicotine (two forms: nicotine free base, FW show much absorption at 320 nm, standardization was 162.2; and (-)-nicotine hemisulphate salt, FW 211.3), not performed in these experiments and gpCSTM was benzo[a]pyrene, glutathione, superoxide dismutase (SOD) directly diluted 10, 25, 50, 75 or 100 fold as indicated and catalase (CAT) were from Sigma (Deisenhofen, in the experiment. Germany). Deferoxamine mesylate was a gift from Ciba Geigy (Wehr, Switzerland). Porcine elastase was from Elastin Products Co. (Owensville, USA). 1R1 reference Isolation of alveolar type II cells cigarettes and Cambridge Filters were purchased from the Tobacco & Health Research Institute at the University Alveolar type II cells were isolated from male, ado- of Kentucky (Lexington, USA). 3H-labelled choline and lescent Sprague Dawley rats by elastase digestion, and 3H-labelled adenosine were from Amersham Buchler differential adherence on IgG-coated Petri dishes as (Braunschweig, Germany). described previously [8, 9]. Type II cells were 88+6.8% pure at the time of plating, judged by modified Papanico- laou staining [10]. Cells were plated at a density of 7.5× Preparation of cigarette smoke-treated medium 105 cells·35 mm dish-1 and were cultured in DMEM with 10% foetal calf serum (FCS), penicillin (100 U·mL-1), Smoke generated by the combustion of four 1R1 ciga- gentamicin (50 µg·mL-1) and L-glutamine (2 mM) at rettes was bubbled through 100 mL of DMEM in a con- 37°C, in room air with 10% CO2. Cells were labelled ical 250 mL culture flask. Suction was regulated, so that with 3H-choline (1 µCi·mL-1 DMEM) for 22h. After this sidestream smoke developed during the entire combus- time, adherent cells were washed four times with DMEM. tion, lasting 3 min for each cigarette. Absorbance of cigarette smoke-treated medium (CSTM) was measured at 320 nm (see below). CSTM was then diluted 10, 25, Secretion assay 50, 75 or 100 fold with fresh DMEM. A 10 fold dilu- tion will be indicated in graphs as 1:10. To standardize PC secretion was measured by labelling cells with 3H- the concentration of CSTM, dilution was adjusted as choline as indicated, removing excess label in the super- described below. Finally, CSTM was incubated for 90 natant by washing, stimulating secretion with agonists, min at 37˚C, in room air with 10% CO2. The pH of harvesting the supernatant including secreted material CSTM was not different from that of untreated DMEM. and measuring radioactivity in the lipophilic phase by scintillation counting (i.e. cell-synthesized 3H-phos- phatidylcholine) following lipid extraction [11]. Cells Standardization of CSTM were harvested by scraping in ethanol and processed as described for supernatant. Secretion (i.e. counts in the Preliminary experiments showed maximal absorption supernatant) was then expressed in percentage of total of cigarette smoke treated DMEM (with phenol red) at counts (cells and supernatant). A mixture of 10-4 M 320 nm, when regular DMEM was used as a blank and terbutaline, 10-8 M TPA, and 10-4 M ATP was used in all set to zero. The smoke of four 1R1 cigarettes in these experiments to stimulate surfactant secretion, with the experiments resulted in an absorbance of 1.36. This exception of those experiments examining the influence value was used as a reference for the preparation of of CSTM on secretion stimulated by single agonists of CSTM throughout this study. When CSTM was diluted equal concentrations. The combination of terbutaline, with fresh DMEM, a linear relationship between the TPA and ATP in the concentrations indicated above extent of dilution and absorption was seen (y=0.0015+ resulted in strong stimulation of surfactant secretion in 1.38x; R=0.999). Taking advantage of the linearity of alveolar type II cells and will be referred to as T/T/A.